Director Timothy Wentworth receives 144 DGX phantom units as deferred pay

Rhea-AI Filing Summary

Quest Diagnostics director Timothy C. Wentworth reported a routine compensation-related transaction involving deferred equity-based awards. He received 144 Phantom Stock Units, representing an elective deferral of his director cash compensation under the company’s Amended and Restated Deferred Compensation Plan for Directors. Each unit is tied to Quest Diagnostics common stock and is payable in cash when his service as a director ends. Following this grant, he holds 342 Phantom Stock Units in total. This filing reflects a non-cash grant/award acquisition rather than an open-market stock purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider WENTWORTH TIMOTHY C

Role null

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock Units	144	$0.00	--

Holdings After Transaction: Phantom Stock Units — 342 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Phantom Stock Units granted: 144 units Phantom Stock Units after transaction: 342 units Transaction price per unit: $0.0000 +1 more

4 metrics

Phantom Stock Units granted 144 units Grant/award acquisition on 2026-07-01

Phantom Stock Units after transaction 342 units Total units beneficially owned following grant

Transaction price per unit $0.0000 Grant price for Phantom Stock Units

Underlying common stock equivalent 144 shares Underlying Quest Diagnostics common stock for the new units

Key Terms

Phantom Stock Units, elective deferrals, Deferred Compensation Plan for Directors, derivative, +1 more

5 terms

Phantom Stock Units financial

"Phantom stock units resulting from elective deferrals of a director's cash compensation"

Phantom stock units are company promises that pay a cash or stock-equivalent award tied to the firm’s share price or value growth, but they do not issue actual shares. Think of them as a bonus check that moves with the stock like a mirror rather than handing over an ownership slice. Investors care because these awards can affect a company’s future cash obligations, executive incentives and reported expenses without causing share dilution.

elective deferrals financial

"Phantom stock units resulting from elective deferrals of a director's cash compensation"

Deferred Compensation Plan for Directors financial

"pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors"

A deferred compensation plan for directors is an arrangement that lets board members postpone receiving part of their pay until a later date—often retirement or a set future time—so the money can grow or be paid under specified conditions. Think of it like directing a portion of your paycheck into a locked savings account that pays out later; investors care because it creates future cash or stock obligations, signals how the company motivates and retains leadership, and can affect shareholder value through timing of payouts or potential dilution.

derivative financial

"transaction_type": "derivative""

A derivative is a financial contract whose value depends on the price or performance of another asset or measure — for example a stock, index, interest rate, commodity, or currency. Investors use derivatives like insurance or leveraged bets to hedge risk, speculate, or gain exposure without owning the underlying asset; they can protect portfolios but also amplify losses and introduce counterparty and market risk.

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/02/2026 - 04:34 PM Accepted by SEC EDGAR 07/02/2026 - 04:34 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WENTWORTH TIMOTHY C

(Last) (First) (Middle)

500 PLAZA DRIVE

C/O QUEST DIAGNOSTICS INC

(Street)

SECAUCUS NEW JERSEY 07094

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
QUEST DIAGNOSTICS INC [ DGX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock Units	$0	07/01/2026		A		144		(1)	(1)	Common Stock	144	$0	342	D

Explanation of Responses:

1. Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.

Remarks:

	Sean D. Mersten, Attorney in Fact for Timothy C. Wentworth	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Quest Diagnostics (DGX) director Timothy C. Wentworth report on this Form 4?

Timothy C. Wentworth reported receiving 144 Phantom Stock Units as a grant under Quest Diagnostics’ deferred compensation plan for directors. These units represent deferred director fees and are linked to the value of Quest Diagnostics common stock, but are ultimately payable in cash.

How many Phantom Stock Units does Timothy C. Wentworth hold after this DGX transaction?

After this transaction, Timothy C. Wentworth holds a total of 342 Phantom Stock Units. The filing shows a grant of 144 new units, bringing his post-transaction balance to 342, all recorded as directly owned derivative securities linked to Quest Diagnostics common stock.

Is Timothy C. Wentworth buying or selling Quest Diagnostics (DGX) stock in this Form 4?

This Form 4 does not show open-market buying or selling of Quest Diagnostics shares. Instead, it reports a grant of 144 Phantom Stock Units as deferred director compensation, which are derivative units payable in cash rather than a direct purchase or sale of common stock.

What are Phantom Stock Units in the Quest Diagnostics director deferred compensation plan?

Phantom Stock Units are bookkeeping units tied to Quest Diagnostics common stock value, used in the director deferred compensation plan. According to the filing, these units result from elective deferrals of a director’s cash compensation and become payable in cash when the director’s service ends.

When will Timothy C. Wentworth receive cash from these Quest Diagnostics Phantom Stock Units?

The filing states that Phantom Stock Units become payable in cash upon Timothy C. Wentworth’s termination of service as a director. Until then, they remain deferred compensation entries linked to the value of Quest Diagnostics common stock, not currently paid out or settled.